Renaud Seigneuric holds a French and a Canadian PhD in Biomedical Engineering. He completed his postdoctoral fellowship at the Maastro lab, one of the 5 Siemens centres of excellence (Maastricht, the Netherlands). He patented, together with clinicians, lists of biomarkers leading towards more individualized cancer therapies. He was appointed in 2007 as assistant professor in biophysics (University de Bourgogne, Faculty of Medicine and Pharmacy, Dijon, France). Working at different scales, his translational research is devoted to cancer detection and treatment. He was recently nominated by the Who’s Who in Medicine and Healthcare (2011-2012). Renaud Seigneuric holds a French and a Canadian PhD in Biomedical Engineering. He completed his postdoctoral fellowship at the Maastro lab, one of the 5 Siemens centres of excellence (Maastricht, the Netherlands). He patented, together with clinicians, lists of biomarkers leading towards more individualized cancer therapies. He was appointed in 2007 as assistant professor in biophysics (University de Bourgogne, Faculty of Medicine and Pharmacy, Dijon, France). Working at different scales, his translational research is devoted to cancer detection and treatment. He was recently nominated by the Who’s Who in Medicine and Healthcare (2011-2012).

Biomarker